Your search Losartan potassium did not match any manufacturers. You may consider to:
Check the spelling
Use less keywords
Use different keywords
Losartan potassium suppliers
Losartan potassium
- CAS:
- 124750-99-8
- MF:
- C22H23ClKN6O
- MW:
- 462.01
Suppliers by country/region
- Israel(2)
- China(249)
- United States(83)
- India(239)
- United Kingdom(23)
- Canada(11)
- Europe(2)
- South Korea(20)
- Germany(6)
- Switzerland(3)
- Japan(4)
- Slovenia(1)
- Brazil(6)
- Czech Republic(1)
- France(4)
- Spain(2)
- Poland(1)
- Egypt(1)
- Turkey(1)
- Singapore(1)
- The Netherlands(2)
- Italy(2)
- Slovakia(1)
- Belgium(1)
- Nigeria(1)
- Greece(1)
- Mexico(1)
- Bangladesh(1)
- United Arab Emirates(1)
- Austria(1)
- Iran(1)
- Argentina(1)
- Jordan(1)
- Malaysia(1)
- Nepal(1)
Company Type
Properties
- Melting point:
- 263-265°C
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- Freely soluble in water and in methanol, slightly soluble in acetonitrile.
- form
- powder or crystals
- color
- Off-white
- Merck
- 14,5583
- BRN
- 5845770
- BCS Class
- 1
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 2 months.
- InChI
- InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1
- InChIKey
- OXCMYAYHXIHQOA-UHFFFAOYSA-N
- SMILES
- C1(C=CC=CC=1C1=CC=C(CN2C(CO)=C(Cl)N=C2CCCC)C=C1)C1=NN=NN1[K]
- CAS DataBase Reference
- 124750-99-8(CAS DataBase Reference)
Safety Information
- Symbol(GHS)
GHS07
- Signal word
- Warning
- Hazard statements
- H315-H319-H335
- Precautionary statements
- P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362+P364-P403+P233-P501c
- Hazard Codes
- Xi
- Risk Statements
- 36/37/38
- Safety Statements
- 26-36/37/39
- WGK Germany
- 3
- RTECS
- NI6755100
- HS Code
- 2933290000
Use
Losartan potassium is the first potent and selective non-peptide angiotensin II (AT II) AT1 receptor antagonist introduced to the market as a once-daily oral antihypertensive. It is efficacious and long lasting in controlling blood pressure in spontaneous hypertensive rats, in patients with essential hypertension in addition to those patients with renal impairment. Since losartan functions by competitive antagonism at the level of receptor, which represents the most direct way of selectively inhibiting the renin-angiotensin system (RAS) independent of the source of AT II, its use has been reported to be free of the coughing side effect exhibited by the ACE inhibitors. In contrast to calcium channel blockers, losartan does not appear to cause ankle edema, headache and tachycardia. It is also reported to be in clinical trials for the treatment of heart failure. Other reports indicate that losartan may have potential efficacy as an anxiolytic, an antiglaucoma agent, in addition to in providing protection against stroke and in preventing the myointimal proliferative response of the vascular wall after coronary angioplasty and surgery.
Your search Losartan potassium did not match any manufacturers. You may consider to: